GALENA BIOPHARMA, INC. FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

Edgar Glimpses |

Item 5.07 SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS

Annual Meeting of Stockholders

The Annual Meeting of stockholders of Galena Biopharma, Inc. ("we," "us," "our" or the "company") was held on June 27, 2014. On April 30, 2014, we filed with the Securities and Exchange Commission our definitive proxy statement relating to the Annual Meeting.



At the Annual Meeting, our stockholders acted upon the following proposals, which are described in detail in our proxy statement: • Proposal 1: To re-elect William L. Ashton, Richard Chin, M.D. and Rudolph Nisi, M.D. as Class I Directors to serve until the 2017 Annual Meeting of stockholders; • Proposal 2: To approve, by non-binding vote, the compensation of our named executive officers as disclosed in our proxy statement; and • Proposal 3: To ratify the appointment of Moss Adams LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014.

Voting Results

Proposal 1: Mr. Ashton and Drs. Chin and Nisi were re-elected as Class I Directors by the following votes:

"FOR" "WITHHELD" William L. Ashton 15,860,921 2,035,392 Richard Chin, M.D. 14,564,801 3,331,512 Rudolph Nisi, M.D. 14,094,843 3,801,470

In addition, there were 67,415,925 broker non-votes in connection with this proposal.

Proposal 2: This proposal was approved with 12,544,457 votes "FOR," 4,735,686 votes "AGAINST," and 616,170 votes to "ABSTAIN." In addition, there were 67,415,925 broker non-votes in connection with this proposal.

Proposal 3: This proposal was approved with 80,310,876 votes "FOR," 3,873,038 votes "AGAINST," and 1,128,324 votes to "ABSTAIN." There were no broker non-votes in connection with this proposal.

--------------------------------------------------------------------------------

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
TIRTZ Tidelands Royalty Trust B 1.80 0.00 0.00 0

Comments

Emerging Growth

GSV Capital Corp

GSV Capital Corp is an externally managed, non-diversified closed-end management investment company. The Company has elected to be treated as a business development company.

Private Markets

8tracks

Our mission is to be the best place for people who care about music to create and discover thoughtfully curated playlists. In essence, 8tracks is a platform for online mixtapes.

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…